CUSIP: 91381U101
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,306,266
-
Share change
-
-585,283
-
Total reported value
-
$121,833,828
-
Put/Call ratio
-
124%
-
Price per share
-
$6.00
-
Number of holders
-
86
-
Value change
-
-$3,200,586
-
Number of buys
-
35
-
Number of sells
-
33
Quarterly Holders Quick Answers
What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2021
-
Previous quarter:
Q4 2020
Recent filing periods for CUSIP 91381U101:
Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q1 2021
As of 31 Mar 2021,
UNITY BIOTECHNOLOGY INC - COM (UBX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,306,266 shares.
The largest 10 holders included
FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Mayo Clinic, Invus Financial Advisors, LLC, STATE STREET CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, and Founders Fund V Management, LLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.